Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes

Clinical trial NCT00787384 · COMPLETED

Trial details

NCT number: NCT00787384
Sponsor: Northern Italy Leukemia Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypereosinophilic Syndrome Chronic Eosinophilic Leukemia Chronic Idiopathic Hypereosinophilia

Start date: 2004-10-01
Primary completion: 2007-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.